AKT1 and cancer: A total of 20 pathways (p < 0.05) were found to be involved by the targets of this RA (Figure 3b), including the “rap1 signaling pathway”, “PI3K-Akt signaling pathway”, “proteoglycans in cancer” and “focal adhesion”.